HEPAVAC Project: a personalized approach to develop a cure for liver cancer
The HEPAVAC project aims at developing a protocol for the production of personalized
vaccines for patients affected by hepatocellular carcinoma (HCC), a primary form of liver
cancer having a high death rate.
Coordinator: Prof. Buonaguro
Coordinating Institute: Istituto Nazionale Tumori "PASCALE", Naples, Italy